Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Consider this
7
Apr 12, 2008 11:35AM
16
Apr 13, 2008 07:52AM
1
Apr 13, 2008 08:16AM
2
Apr 13, 2008 08:30AM
2
Apr 13, 2008 09:18AM
4
Apr 13, 2008 09:30AM
10
Apr 13, 2008 09:50AM

Apr 13, 2008 10:18AM
1
Apr 13, 2008 10:27AM
1
Apr 13, 2008 11:10AM
2
Apr 13, 2008 11:21AM

Apr 13, 2008 11:25AM

Apr 13, 2008 11:28AM

It is interesting to note that the fiscal year for both Toshiba and Matsushita ends March 31, 2008, I believe. So a possibility that they wanted to defer any payments until the new fiscal year starting April 1st.

And, given what has transpired with the exchange rate, perhaps Js would have wanted a yen royalty. We get USD based on the current exchage rate. Which would further obscure what they are paying. But then, doesn't PTSC have to tell shareholder's at least that revenue recognition has changed, or they expect royalty payments in the future? Not how much, or from whom, but just that the situation exists? This is why I keep thinking in terms of business resolution meaning just that. Opty


Apr 13, 2008 12:16PM

Apr 13, 2008 12:37PM
5
Apr 13, 2008 12:46PM
3
Apr 13, 2008 12:57PM
1
Apr 13, 2008 12:58PM
1
Apr 13, 2008 01:17PM

Apr 13, 2008 01:24PM
Share
New Message
Please login to post a reply